Propel Bio Management, LLC
- SEC CIK
- 0001969764
- Latest filing
- Aug 13, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 12, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 16
- 0 vs. Q2 2025
- Portfolio value
- $99.9M
- +$17.5M (+21.2%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PAGPPlains GP Holdings LP | LTD PARTNR INT A | 1,272,360 | $23.2M | 23.2% | 00.0% | Unchanged | History |
| ACHVAchieve Life Sciences, Inc. | COM | 3,786,425 | $11.9M | 11.9% | −2,366,666−38.5% | Reduced | History |
| AKROAkero Therapeutics, Inc. | COM | 228,884 | $10.9M | 10.9% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 5,124,890 | $10.2M | 10.3% | +3,333,333+186.1% | Added | History |
| APLTApplied Therapeutics, Inc. | COM | 11,285,420 | $6.83M | 6.8% | 00.0% | Unchanged | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 552,927 | $6.51M | 6.5% | −370,000−40.1% | Reduced | History |
| ABEOAbeona Therapeutics Inc. | COM NEW | 974,022 | $5.14M | 5.1% | 00.0% | Unchanged | History |
| DCTHDelcath Systems, Inc. | COM NEW | 438,509 | $4.71M | 4.7% | +212,457+94.0% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 155,000 | $4.01M | 4.0% | +155,000 | New | History |
| TCRXTScan Therapeutics, Inc. | COM | 1,932,304 | $3.52M | 3.5% | −154,835−7.4% | Reduced | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 510,000 | $2.92M | 2.9% | +510,000 | New | History |
| NKTRNektar Therapeutics | COM NEW | 49,000 | $2.79M | 2.8% | +49,000 | New | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 1,028,806 | $2.45M | 2.5% | +1,028,806 | New | History |
| ZVRAZevra Therapeutics, Inc. | COM NEW | 231,874 | $2.21M | 2.2% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 90,000 | $1.94M | 1.9% | +90,000 | New | History |
| LONALeonaBio, Inc. | COM | 149,279 | $618.0K | 0.6% | 00.0% | UnchangedConverted for a 1-for-10 split | History |
Sold out since Q2 2025 (5)
Positions held at the end of Q2 2025 that are gone from this filing.
| Security | Class | Shares in Q2 2025 | Value in Q2 2025 | % of portfolio in Q2 2025 | History |
|---|---|---|---|---|---|
| CAPRCapricor Therapeutics, Inc. | COM NEW | 70,000 | $695.1K | 0.8% | History |
| Maat Pharma SacaF5888J116 | COMM | 94,181 | $452.1K | 0.5% | – |
| EIGREiger BioPharmaceuticals, Inc. | COM NEW | 146,381 | $423.0K | 0.5% | History |
| WTS - Achieve Life Sci004468187 | COMM | 3,699,999 | $13.7K | <0.1% | – |
| Contra Chinook Therapeu169CVR016 | COM | 79,357 | $2.50K | <0.1% | – |